Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Viking Therapeutics Inc (VKTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Viking Therapeutics Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
71.565 +2.705    +3.93%
14:26:13 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 2,306,569
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 68.220 - 72.490
Viking Therapeutics Inc 71.565 +2.705 +3.93%

NASDAQ:VKTX Financials

 
A brief overview of the NASDAQ:VKTX financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Viking Therapeutics Inc over time.

Viking Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 27.36 million compared to USD 19.53 million a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.25 a year ago. Diluted loss per share from continuing operations was USD 0.26 compared to USD 0.25 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

VKTX Income Statement

Gross margin TTM -
Operating margin TTM 0%
Net Profit margin TTM 0%
Return on Investment TTM -18.37%
 Total Revenue  Net Income
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Revenue
Gross Profit
Operating Income -34.07 -29.28 -27.26 -23.74
Net Income -27.36 -24.6 -22.53 -19.22

VKTX Balance Sheet

Quick Ratio MRQ 29.38
Current Ratio MRQ 29.48
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 0.13%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Assets 967.52 368.49 382.66 400.69
Total Liabilities 33.63 20.07 14.42 14.58
Total Equity 933.89 348.42 368.24 386.12

VKTX Cash Flow Statement

Cash Flow/Share TTM -0.67
Revenue/Share TTM -
Operating Cash Flow  0.00%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -17.64 -19.66 -11.44
Cash From Investing Activities 35.73 -12.53 -204.48
Cash From Financing Activities 0.188 -0.074 267.08
Net Change in Cash 18.33 -32.33 51.16
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VKTX Comments

Write your thoughts about Viking Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
AHMAD ALHAWAMDE
AHMAD ALHAWAMDE Apr 01, 2024 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
100
Ciprian Gal
Ciprian Gal Mar 27, 2024 12:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
too much exuberance
Amit Shohet
Amit Shohet Mar 14, 2024 8:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Something big is coming.
Kwame Mensah
Kwame Mensah Mar 11, 2024 12:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
??!!
donald terry
donald terry Mar 05, 2024 7:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
amazing.. since this company's been in existence it hasn't made a nickel! so let's double the value triple it!
James Overstreet
James Overstreet Mar 05, 2024 7:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Neither has uber
Wayne Ubsdell
Wayne Ubsdell Mar 05, 2024 7:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Uber is profitable now. Viking does not have any debt either. I am taking a punt,risky for sure !!!
donald terry
donald terry Feb 28, 2024 6:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
so in a cash strap Society the first thing you're buying.. is a weight loss drug!?! you can't even buy food.. there's your diet!
Neil Young
Neil Young Feb 27, 2024 4:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
New Weight-loss Drug
donald terry
donald terry Feb 27, 2024 4:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
just read that..
donald terry
donald terry Feb 27, 2024 4:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I've got a new best selling book entitled.. get off your ass fatty!
donald terry
donald terry Feb 27, 2024 4:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
so what kind of fraud.. happened today with this company?
Korey Curtis
Korey Curtis Feb 27, 2024 2:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pfizer's CEO quashes rumors of Viking Therapeutics acquisition
Korey Curtis
Korey Curtis Feb 27, 2024 2:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What triggered the after hour buy? Any feedback is appreciated. I dont see announcements, FDA approval, earnings etc.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email